Untitled design (11)-1
LIVE WEBINAR

How Cancer Care Northwest Made Germline Genetic Testing Routine In Oncology

CCNW Achieved Rates 11x Higher Than the National Average

1pm ET / 12 pm CT / 11am PT
ABOUT THE WEBINAR

Germline genetic testing is one of the most powerful ways to prevent cancer and detect it earlier — but many oncology teams don’t have the capacity to implement it effectively. Despite clear clinical guidelines, most programs struggle to identify eligible patients or move them through a referral-based process. A JAMA study found that only 6.8% of eligible cancer patients undergo germline testing after diagnosis.

At Cancer Care Northwest (CCNW), that story looks different. Their oncology team is not only identifying eligible patients but also closing the loop — ensuring testing actually happens. By replacing a traditional referral model with a point-of-care testing approach, CCNW has achieved a 78.3% germline testing rate — more than 11× the national average.

Their success came from choosing the right tools for their team — digital workflows that helped specialists and advanced practice providers work at the top of their license, and access to genetics expertise that filled the gaps where capacity was limited. The result: a practical, scalable model that brings prevention and early detection directly into oncology care.

In this session, Jennifer Lazzara, DNP, ARNP, CGRA, ARNP Supervisor at CCNW, will share how her team made this transformation possible. She’ll be joined by Breanna Roscow, MS, CGC, Medical Science Liaison | Certified Genetic Counselor at Myriad Genetics, to discuss how other oncology programs can build similar models to close the testing gap and expand access to prevention and early detection.

What you'll learn:

  • How to make germline genetic testing a seamless part of oncology workflows
  • How to equip oncologists and APPs to deliver testing confidently at the point of care
  • How leading oncology programs are choosing the right tools to close the loop and improve access

Join us for a practical discussion about how prevention and precision can finally come together — and how your oncology team can lead the way.

ABOUT THE SPEAKERS
 12
Jennifer Lazzara DNP, ARNP, CGRA
DNP, ARNP, CGRA, Cancer Care Northwest Jennifer has a Doctor of Nursing Practice degree from University of Utah and is certified in Cancer Genetic Risk Assessment (CGRA) through the National Consortium of Breast Centers (NCBC), having completed the City of Hope Intensive Course in Genetic Cancer Risk Assessment. She provides personalized cancer risk assessment and genetic testing of all patients, as well as medical management of women at high risk for breast cancer. She also provides care to patients who are undergoing treatment for benign and malignant breast conditions. Jennifer manages the team of Advanced Practice Providers at Cancer Care Northwest and works closely with providers, managers, administration and owners at her practice.

 

11

Breanna Roscow, CGC, Myriad Genetics
Breanna Roscow is a certified genetic counselor with extensive clinical experience in oncology and hereditary cancer risk assessment. She is a Medical Science Liaison at Myriad Genetics, where she has spent the past five years supporting healthcare providers through scientific education and clinical collaboration. Breanna has a passion for research and genetic counselor training, and she is dedicated to advancing the field through mentorship and evidence-based practice.